Journal Title：Drug Safety

Drug Safety is the official journal of the International Society of Pharmacovigilance. The journal includes:

Overviews of contentious or emerging issues.

Comprehensive narrative reviews that provide an authoritative source of information on epidemiology, clinical features, prevention and management of adverse effects of individual drugs and drug classes.

In-depth benefit-risk assessment of adverse effect and efficacy data for a drug in a defined therapeutic area.

Systematic reviews (with or without meta-analyses) that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by the PRISMA statement.

Original research articles reporting the results of well-designed studies in disciplines such as pharmacoepidemiology, pharmacovigilance, pharmacology and toxicology, and pharmacogenomics.

Editorials and commentaries on topical issues.

Additional digital features (including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in Drug Safety Drugs may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand important medical advances.

Drug Safety 是国际药物警戒学会的官方期刊。期刊包括：

对有争议或新出现的问题的概述。

全面的叙述性评论，提供有关流行病学、临床特征、预防和管理个别药物和药物类别的不良反应的权威信息来源。

对药物在特定治疗领域的副作用和疗效数据进行深入的收益-风险评估。

使用 PRISMA 声明中概述的明确、系统的方法，整理经验证据以回答特定研究问题的系统评价（有或没有荟萃分析）。

原创研究文章报告了药物流行病学、药物警戒、药理学和毒理学以及药物基因组学等学科精心设计的研究结果。

关于热点问题的社论和评论。

其他数字功能（包括动画摘要、视频摘要、幻灯片、音频幻灯片、教学视频、信息图表、播客和动画）可以与文章一起发布；这些旨在提高期刊内容的知名度、读者群和教育价值。此外，在 Drug Safety Drugs 上发表的文章可能会附有简明的语言摘要，以帮助对该领域有一定了解但不具备深入专业知识的读者了解重要的医学进展。